menu
    • menu

    Global sales information and US Prescriptions data of Crisaborole obtained from Centers for Medicare & Medicaid Services Website

    Client Email Product
    Virupaksha Crisaborole RM

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass

    Synopsis

    Related ProductsRelated Products

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    31

    API Suppliers

    API Suppliers

    11

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    4

    EU WC

    EU WC

    0

    KDMF

    KDMF

    12

    NDC API

    NDC API

    0

    VMF

    NDC API

    24

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 6,038

    MARKET PLACE

    8

    API

    0

    FDF

    24INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    4

    FDF Dossiers

    FDF Dossiers

    1

    FDA Orange Book

    FDA (Orange Book)

    0

    Europe

    Europe

    1

    Canada

    Canada

    0

    Australia

    Australia

    2

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    2DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    PATENTS & EXCLUSIVITIES

    8

    US Patents

    1

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    2

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    9

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    10,566,575

    Annual Reports

    352

    Finished Drug Prices

    NA

    11 RELATED EXCIPIENT COMPANIES

    20EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: 906673-24-3, An-2728, An2728, 4-((1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile, Eucrisa, An 2728
    Molecular Formula
    C14H10BNO3
    Molecular Weight
    251.05  g/mol
    InChI Key
    USZAGAREISWJDP-UHFFFAOYSA-N
    FDA UNII
    Q2R47HGR7P
    Crisaborole
    Crisaborole is a novel oxaborole approved by FDA on December 14, 2016 as Eucrisa, a topical treatment of for mild to moderate atopic dermatitis. This non-steroidal agent is efficacious in improving disease severity, reducing the risk of infection and reducing the signs and symptoms in patients 2 years old and older. It reduces the local inflammation in the skin and prevents further exacerbation of the disease with a good safety profile. Its structure contains a boron atom, which facilitates skin penetration and binding to the bimetal center of the phosphodiesterase 4 enzyme. It is currently under development as topical treatment of psoriasis.
    Crisaborole is a Phosphodiesterase 4 Inhibitor. The mechanism of action of crisaborole is as a Phosphodiesterase 4 Inhibitor.
    1 2D Structure

    Crisaborole

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile
    2.1.2 InChI
    InChI=1S/C14H10BNO3/c16-8-10-1-3-12(4-2-10)19-13-5-6-14-11(7-13)9-18-15(14)17/h1-7,17H,9H2
    2.1.3 InChI Key
    USZAGAREISWJDP-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    B1(C2=C(CO1)C=C(C=C2)OC3=CC=C(C=C3)C#N)O
    2.2 Other Identifiers
    2.2.1 UNII
    Q2R47HGR7P
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole

    2. An-2728

    3. An2728

    4. Eucrisa

    2.3.2 Depositor-Supplied Synonyms

    1. 906673-24-3

    2. An-2728

    3. An2728

    4. 4-((1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile

    5. Eucrisa

    6. An 2728

    7. Crisaborole (an2728)

    8. 5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole

    9. 4-[(1-hydroxy-3h-2,1-benzoxaborol-5-yl)oxy]benzonitrile

    10. Crisaborole Topical Ointment 2%

    11. Q2r47hgr7p

    12. 4-((1-hydroxy-1,3-dihydrobenzo-[c][1,2]oxaborol-5-yl)oxy)benzonitrile

    13. Chembl484785

    14. Mfcd17169940

    15. 4-((1-hydroxy-1,3-dihydrobenzo(c)(1,2)oxaborol-6-yl)oxy)benzonitrile

    16. 906673-25-4

    17. Staquis

    18. 4-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)benzonitrile

    19. 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile

    20. 4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile

    21. Benzonitrile, 4-((1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy)-

    22. 4-[(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy]benzonitrile

    23. Crisaborole [usan]

    24. Unii-q2r47hgr7p

    25. Crisaborole [inn]

    26. Eucrisa (tn)

    27. Crisaborole [mi]

    28. Crisaborole (usan/inn)

    29. Crisaborole [usan:inn]

    30. Crisaborole(an-2728)

    31. Crisaborole [who-dd]

    32. Schembl595261

    33. Gtpl9151

    34. Crisaborole, >=98% (hplc)

    35. Crisaborole [orange Book]

    36. Dtxsid10238231

    37. Tqp0866

    38. Chebi:134677

    39. Bcp08677

    40. Ex-a1087

    41. Bdbm50277665

    42. Akos016005425

    43. Zinc169748244

    44. Ccg-266972

    45. Cs-1057

    46. Db05219

    47. Sb16802

    48. Compound 5b [pmid: 19303290]

    49. Ncgc00345792-01

    50. Ncgc00345792-02

    51. Ncgc00345792-04

    52. Ac-30331

    53. As-70551

    54. Hy-10978

    55. Sy113089

    56. Db-078771

    57. Ft-0767999

    58. S5014

    59. Pf-06930164

    60. C90571

    61. C90670

    62. D10873

    63. F51164

    64. 5-(4-cyanophenoxy)-1-hydroxy-2,1-benzoxaborole

    65. Q21098894

    66. Crisaborole;4-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)benzonitrile;an-2728

    67. 1073669-75-6

    2.4 Create Date
    2010-01-26
    3 Chemical and Physical Properties
    Molecular Weight 251.05 g/mol
    Molecular Formula C14H10BNO3
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count2
    Exact Mass251.0753733 g/mol
    Monoisotopic Mass251.0753733 g/mol
    Topological Polar Surface Area62.5 Ų
    Heavy Atom Count19
    Formal Charge0
    Complexity361
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Intended for the topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older.

    FDA Label

    Staquis is indicated for treatment of mild to moderate atopic dermatitis in adults and paediatric patients from 2 years of age with 40% body surface area (BSA) affected.

    5 Pharmacology and Biochemistry
    5.1 Pharmacology

    Crisaborole has broad-spectrum anti-inflammatory activity by mainly targeting phosphodiesterase 4 (PDE4) enzyme that is a key regulator of inflammatory cytokine production. As this enzyme is expressed in keratinocytes and immune cells, crisaborole mediates an anti-inflammatory effect on almost all inflammatory cells. Topical application of this drug is useful as it potentiates the localization of this drug in the skin and this anti-inflammatory activity is in the low micromolar range.

    5.2 FDA Pharmacological Classification
    5.2.1 Active Moiety
    CRISABOROLE
    5.2.2 FDA UNII
    Q2R47HGR7P
    5.2.3 Pharmacological Classes
    Phosphodiesterase 4 Inhibitors [MoA]; Phosphodiesterase 4 Inhibitor [EPC]
    5.3 ATC Code

    D11AH06

    D - Dermatologicals

    D11 - Other dermatological preparations

    D11A - Other dermatological preparations

    D11AH - Agents for dermatitis, excluding corticosteroids

    D11AH06 - Crisaborole

    5.4 Absorption, Distribution and Excretion

    Absorption

    Systemic concentrations of crisaborole were reached by 8 days of twice-daily topical administration. It has low systemic absorption thus poses less risk for developing systemic side effects.

    Route of Elimination

    Renal excretion of metabolites is the major route of elimination.

    5.5 Metabolism/Metabolites

    Crisaborole is substantially metabolized into inactive metabolites. The major metabolite 5-(4-cyanophenoxy)-2-hydroxyl benzylalcohol (metabolite 1), is formed via hydrolysis; this metabolite is further metabolized into downstream metabolites, among which 5-(4-cyanophenoxy)-2-hydroxyl benzoic acid (metabolite 2), formed via oxidation, is also a major metabolite.

    5.6 Mechanism of Action

    Inhibition of PDE4 by crisaborole leads to elevated levels of cyclic adenosine monophosphate (cAMP). Increased intracellular levels of cAMP inhibit the NF-kB pathway and suppress the release of pro-inflammatory mediators such as TNF-alfa and various interleukins that play a causative role in psoriasis and atopic dermatitis. Suppression of downstream effects in different cell types may explain the therapeutic role of crisaborole in immune-mediated skin diseases.

    API SUPPLIERS

    read-more
    read-more
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Reference Price

    read-more
    read-more
    [{"dataSource":"API Export","activeIngredients":"CRISABOROLE","year":"2021","qtr":"Q1","strtotime":1612204200,"product":"CRISABOROLE MFG DATE 08-07-2018 RETEST DATE 07.07.2021 BATCH NO 4035\/3\/001\/18","address":"","city":"","supplier":"MINHA ENTERPRISES","supplierCountry":"INDIA","foreign_port":"JEDDAH","customer":"JAMJOOM PHARMACEUTICALS COMPANY","customerCountry":"SAUDI ARABIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"17895.1","totalValueFC":"35418.3","currency":"USD","unitRateINR":1289344.5,"date":"02-Feb-2021","totalValueINR":"2578689","totalValueInUsd":"35418.3","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8335664","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"SAUDI ARABIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"CRISABOROLE","year":"2021","qtr":"Q1","strtotime":1612809000,"product":"PHARMACEUTICAL RAW MATERIAL CRISABOROLE","address":"407\/408,SHARDA CHAMBERS,NEW MARINE LINES,","city":"MUMBAI, MAHARASHTRA.","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"AMPHARCO USA","customerCountry":"EGYPT","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"8939.1","totalValueFC":"13269.3","currency":"USD","unitRateINR":644061.00666666671,"date":"09-Feb-2021","totalValueINR":"966091.51","totalValueInUsd":"13269.3","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8520253","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408,SHARDA CHAMBERS,NEW MARINE LINES,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1622485800,"product":"CRISABOROLE (TAX INV.VOL1\/DOM\/163 DT.25- 05-2021) (GST NO.36AABCD0026F1ZB)","address":"B-4, IDA, GANDHI NAGAR,","city":"HYDERABAD, TELANGANA.","supplier":"VIRUPAKSHA ORGANICS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"MEDIZEN PHARMACEUTICAL INDUSTRIES","customerCountry":"EGYPT","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"14897","totalValueFC":"7297","currency":"USD","unitRateINR":1073330,"date":"01-Jun-2021","totalValueINR":"536665","totalValueInUsd":"7297","indian_port":"HYDERABAD AIR","hs_no":"29335990","bill_no":"2133173","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"B-4, IDA, GANDHI NAGAR,, HYDERABAD, TELANGANA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1626633000,"product":"CRISABOROLE","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"KARACHI","customer":"HIRANIS PHARMACEUTICAL PVT ","customerCountry":"PAKISTAN","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"34.7","totalValueFC":"3428.9","currency":"USD","unitRateINR":2555.46,"date":"19-Jul-2021","totalValueINR":"255546","totalValueInUsd":"3428.9","indian_port":"Vizag-HIPL SEZ","hs_no":"29269000","bill_no":"4000551","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648405800,"product":"CRISABOROLE","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"GUANGZHOU GREENSYN PHARMA ","customerCountry":"CHINA","quantity":"0.20","actualQuantity":"200","unit":"GMS","unitRateFc":"12.4","totalValueFC":"2446.5","currency":"USD","unitRateINR":932.36000000000001,"date":"28-Mar-2022","totalValueINR":"186472","totalValueInUsd":"2446.5","indian_port":"Vizag-HIPL SEZ","hs_no":"29269000","bill_no":"4000235","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1652639400,"product":"CRISABOROLE","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"GUANGZHOU TOSUN PHARMACEUTICAL","customerCountry":"CHINA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"7472.4","totalValueFC":"7285.2","currency":"USD","unitRateINR":563042,"date":"16-May-2022","totalValueINR":"563042","totalValueInUsd":"7285.2","indian_port":"Vizag-HIPL SEZ","hs_no":"29269000","bill_no":"4000365","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1653935400,"product":"CRISABOROLE (OTHER) (LUT (ARN) NO AD2","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"MAPHIN","customerCountry":"EGYPT","quantity":"4.35","actualQuantity":"4.35","unit":"KGS","unitRateFc":"10440","totalValueFC":"45014.8","currency":"USD","unitRateINR":799770.11494252877,"date":"31-May-2022","totalValueINR":"3479000","totalValueInUsd":"45014.8","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"1799285","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1658169000,"product":"CRISABOROLE","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"SHANGHAI","customer":"SHANDONG BESTCOMM PHARMACEUTICCAL CO LTD","customerCountry":"CHINA","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"3851.1","totalValueFC":"3787.4","currency":"USD","unitRateINR":301158,"date":"19-Jul-2022","totalValueINR":"301158","totalValueInUsd":"3787.4","indian_port":"Vizag-HIPL SEZ","hs_no":"29269000","bill_no":"4000518","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659637800,"product":"CRISABOROLE (OTHER) (LUT (ARN) NO AD270","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MONTEVIDEO -","customer":"PEISRL","customerCountry":"URUGUAY","quantity":"4.30","actualQuantity":"4.3","unit":"KGS","unitRateFc":"9360","totalValueFC":"39287.6","currency":"USD","unitRateINR":726976.74418604653,"date":"05-Aug-2022","totalValueINR":"3126000","totalValueInUsd":"39287.6","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"3313492","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"URUGAY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1666636200,"product":"CRISABOROLE","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"EL QAHIRA (CAIRO)","customer":"AL ANDALOUS FOR PHARMACEUTICAL INDUSTRIES","customerCountry":"EGYPT","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"2985.4","totalValueFC":"8947","currency":"USD","unitRateINR":245397.66666666666,"date":"25-Oct-2022","totalValueINR":"736193","totalValueInUsd":"8947","indian_port":"Vizag-HIPL SEZ","hs_no":"29269000","bill_no":"4000767","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1672770600,"product":"CRISABOROLE","address":"7-1-638 TO 643, 643\/1,FLAT NO. 302 ,,BHANU ENCLAVE, ERRAGADDA","city":"HYDERABAD,TELANGANA","supplier":"METROCHEM API PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"KATHMANDU","customer":"ELIXIR LIFE SCIENCE","customerCountry":"NEPAL","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"460000","totalValueFC":"281.3","currency":"INR","unitRateINR":460000,"date":"04-Jan-2023","totalValueINR":"23000","totalValueInUsd":"281.3","indian_port":"RAXAUL","hs_no":"29335990","bill_no":"6699759","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"NEPAL","selfForZScoreResived":"Pharma Grade","supplierPort":"RAXAUL","supplierAddress":"7-1-638 TO 643, 643\/1,FLAT NO. 302 ,,BHANU ENCLAVE, ERRAGADDA, HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676313000,"product":"CRISABOROLE","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"AMMAN","customer":"ITQAN PHARAMCEUTICAL INDUSTRY","customerCountry":"JORDAN","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"3540.4","totalValueFC":"6948.8","currency":"USD","unitRateINR":286950,"date":"14-Feb-2023","totalValueINR":"573900","totalValueInUsd":"6948.8","indian_port":"Vizag-HIPL SEZ","hs_no":"29269000","bill_no":"4000105","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"JORDAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676572200,"product":"CRISABOROLE","address":"8-3-166\/7\/1, HETERO HOUSE,","city":"HYDERABAD, AP.","supplier":"HONOUR LAB LTD","supplierCountry":"INDIA","foreign_port":"GUANGZHOU","customer":"GUANGZHOU STANDARD PHARMA ","customerCountry":"CHINA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"4281.1","totalValueFC":"8490.6","currency":"USD","unitRateINR":350621,"date":"17-Feb-2023","totalValueINR":"701242","totalValueInUsd":"8490.6","indian_port":"Vizag-HIPL SEZ","hs_no":"29269000","bill_no":"4000117","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Vizag-HIPL SEZ","supplierAddress":"8-3-166\/7\/1, HETERO HOUSE,, HYDERABAD, AP.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1684521000,"product":"CRISABOROLE LUT ARN NOAD270323055216ADT 27 03 2023 TAX INV9240000078 DT19 05 2023","address":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES","city":"MUMBAI,MAHARASHTRA","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"HKPHIN","customerCountry":"EGYPT","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"10000","totalValueFC":"29629","currency":"USD","unitRateINR":812666.66666666663,"date":"20-May-2023","totalValueINR":"2438000","totalValueInUsd":"29629","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"407\/408 SHARDA CHAMBERS,NEW MARINE LINES, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1694889000,"product":"CRISABOROLE","address":"FLAT NO.302, BHANU ENCLAVE","city":"HYDERABAD.AP","supplier":"METROCHEM API PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BIRGUNJ","customer":"KEVA PHARMACEUTICALS PVT.LTD.","customerCountry":"NEPAL","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"260000","totalValueFC":"3132.2","currency":"INR","unitRateINR":260000,"date":"17-Sep-2023","totalValueINR":"260000","totalValueInUsd":"3132.2","indian_port":"Raxaul","hs_no":"29335990","bill_no":"3996228","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"NEPAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Raxaul","supplierAddress":"FLAT NO.302, BHANU ENCLAVE, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1705861800,"product":"CRISABOROLE (OTHER)(LUT(ARN)NOAD270323055216A DT 27\/03\/2023) (TAX INV MH1160000441 DT.16.01.2024)","address":"407\/408,SHARDA CHAMBERS,","city":"MUMBAI, MAHARASHTRA.","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MONTEVIDEO","customer":"N\/A","customerCountry":"URUGUAY","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"6570","totalValueFC":"27412.3","currency":"USD","unitRateINR":455656.20000000001,"date":"22-Jan-2024","totalValueINR":"2278281","totalValueInUsd":"27412.3","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"6938751","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"URUGAY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"407\/408,SHARDA CHAMBERS,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706639400,"product":"CRISABOROLE (OTHER)(LUT(ARN)NOAD270323055216A DT 27\/03\/2023) (TAX INV MH1160000520 DT.29.01.2024)","address":"407\/408,SHARDA CHAMBERS,","city":"MUMBAI, MAHARASHTRA.","supplier":"BDR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"WORLD MEDICINE PHARMACEUTICAL CO,","customerCountry":"TURKEY","quantity":"0.20","actualQuantity":"200","unit":"GMS","unitRateFc":"9.9","totalValueFC":"1779.8","currency":"USD","unitRateINR":739.63065000000006,"date":"31-Jan-2024","totalValueINR":"147926.13","totalValueInUsd":"1779.8","indian_port":"Bombay Air","hs_no":"29335990","bill_no":"7173008","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"407\/408,SHARDA CHAMBERS,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709577000,"product":"CRISABOROLE IN-HOUSE","address":"PLOT NO.131,3RD FLOOR,NARMADA","city":"HYDERABAD. AP","supplier":"OPTIMUS DRUGS PRIVATE ","supplierCountry":"INDIA","foreign_port":"CAIRO","customer":"MARCYRL PHARMACEUTICALS","customerCountry":"EGYPT","quantity":"10.00","actualQuantity":"10","unit":"KGS","unitRateFc":"2711","totalValueFC":"26759.6","currency":"USD","unitRateINR":222200.5,"date":"05-Mar-2024","totalValueINR":"2222005","totalValueInUsd":"26759.6","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"8068255","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.131,3RD FLOOR,NARMADA, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713292200,"product":"CRISABOROLE","address":"FLAT NO.302, BHANU ENCLAVE","city":"HYDERABAD.AP","supplier":"METROCHEM API PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"KATHMANDU","customer":"ELIXIR LIFE SCIENCE","customerCountry":"NEPAL","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"280000","totalValueFC":"3353","currency":"INR","unitRateINR":280000,"date":"17-Apr-2024","totalValueINR":"280000","totalValueInUsd":"3353","indian_port":"Raxaul","hs_no":"29335990","bill_no":"9200110","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"NEPAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Raxaul","supplierAddress":"FLAT NO.302, BHANU ENCLAVE, HYDERABAD.AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715279400,"product":"CRISABOROLE IN-HOUSE","address":"PLOT NO.131,3RD FLOOR,NARMADA","city":"HYDERABAD. AP","supplier":"OPTIMUS DRUGS PRIVATE ","supplierCountry":"INDIA","foreign_port":"EL QAHIRA (= CAIRO)","customer":"M\/S GLOBAL ADVANCED PHARMACEUTICAL,","customerCountry":"EGYPT","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"2724","totalValueFC":"13545.7","currency":"USD","unitRateINR":225817.39999999999,"date":"10-May-2024","totalValueINR":"1129087","totalValueInUsd":"13545.7","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"9767792","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"EGYPT","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.131,3RD FLOOR,NARMADA, HYDERABAD. AP","customerAddress":""},{"dataSource":"API Import","activeIngredients":"CRISABOROLE","year":"2021","qtr":"Q1","strtotime":1612377000,"product":"CRISABOROLE (IMPORT FOR EXPORT)","address":"407\/408,SHARDA CHAMBERS,NEW MARINE LINES,","city":"MUMBAI, MAHARASHTRA.","supplier":"HANGZHOU LONGSHINE BIO-TECH","supplierCountry":"CHINA","foreign_port":"QINGDAO","customer":"BDR PHARMACEUTICALS","customerCountry":"INDIA","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"6000","totalValueFC":"9129","currency":"USD","unitRateINR":"443100","date":"04-Feb-2021","totalValueINR":"664650","totalValueInUsd":"9129","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"2616860","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"QINGDAO","supplierAddress":"","customerAddress":"407\/408,SHARDA CHAMBERS,NEW MARINE LINES,"}]
    02-Feb-2021
    10-May-2024
    KGS
    overview
    Loading...

    Average Price (USD/KGS)

    Number of Transactions

    Total Quantity (KGS)

    Total Value (USD)

    Quantity (KGS) & Unit rate (USD/KGS) over time

    API Imports and Exports

    Importing Country Total Quantity
    (KGS)    		 Average Price
    (USD/KGS)    		 Number of Transactions

    Upgrade, download data, analyse, strategize, subscribe with us contact

    Related Excipient Companies

    Upload your portfolio for free, ask us

    Excipients by Applications

    Click here to find the perfect excipient manufacturers by their capabilities

    Topical

    read-more
    read-more

    Co-Processed Excipients

    read-more
    read-more

    Solubilizers

    read-more
    read-more

    Film Formers & Plasticizers

    read-more
    read-more

    Coating Systems & Additives

    read-more
    read-more

    Emulsifying Agents

    read-more
    read-more

    Thickeners and Stabilizers

    read-more
    read-more

    Parenteral

    read-more
    read-more

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    DATA COMPILATION #PharmaFlow

    read-more
    read-more

    NEWS #PharmaBuzz

    read-more
    read-more

    Global Sales Information

    Do you need Business Intel? Ask us

    Market Place

    Do you need sourcing support? Ask us

    Patents & EXCLUSIVITIES

    Check the patents & exclusivity for this product

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search